Literature DB >> 25337522

Considerations regarding autologus blood injection for tennis elbow tendinopathy.

Hayat Ahmad Khan1, Younis Kamal1, Nazia Hassan2.   

Abstract

Entities:  

Keywords:  Blood Transfusion, Autologous; Epicondylitis, Lateral Humeral; Tennis Elbow

Year:  2014        PMID: 25337522      PMCID: PMC4199299          DOI: 10.5812/traumamon.19225

Source DB:  PubMed          Journal:  Trauma Mon        ISSN: 2251-7472


× No keyword cloud information.
Dear Editor, We read with interest the article by Karimi Mobarakeh et al. (1) titled as “Autologous Blood Injection for Treatment of Tennis Elbow”. We would like to congratulate the authors for taking up such a study. However, we have several considerations regarding this manuscript: What was the number of patients who received the local steroid injections before being in the study and also, what was the duration from the last steroid injection before patients were given the autologous blood injection. After injection, the authors state that “Immobilization via a long arm cast was done for 3 weeks”. Unfortunately, the authors have omitted to mention the reasons leading to cast immobilization. Also, there is no information concerning the occurrence of post injection stiffness of elbow when a 3 weeks long arm cast immobilization was maintained. In the Results column, the manuscript states that “The mean duration of symptoms was 7.9 ± 1.3 months. Table 1 shows results of NPS and VAS before and 1, 3 and 6 months after ABI”. However, there is no table available to support the results. Furthermore, in the results column, the authors say that “The level of patient satisfaction on Verhaar scale is shown in Figure 1; 84% of patients showed a high level of satisfaction at the end of the study. None required a second injection, although some of them were obliged to change their activities”. However, no Figure is shown to justify such data. The authors have mentioned that their results were comparable to other studies. However, the studies mentioned in the reference column had used ultrasound guided autologous blood injection for tennis elbow (2). Only one study from the references has used autologous blood injection similar to the present study (3). We would rather suggest the authors to compare their results with comparable studies to justify their implication for the healthcare policy making. We hope our suggestions will be taken with a positive note and the revised manuscript with all missing Figures and Tables will be made available.
  3 in total

1.  Autologous blood injections for refractory lateral epicondylitis.

Authors:  Scott G Edwards; James H Calandruccio
Journal:  J Hand Surg Am       Date:  2003-03       Impact factor: 2.230

2.  Ultrasound-guided autologous blood injection for tennis elbow.

Authors:  David A Connell; Kaline E Ali; Muaaze Ahmad; Simon Lambert; Steven Corbett; Mark Curtis
Journal:  Skeletal Radiol       Date:  2006-03-22       Impact factor: 2.199

3.  Autologous blood injection for treatment of tennis elbow.

Authors:  Mahmood Karimi Mobarakeh; Ali Nemati; Ali Fazli; Amirhossein Fallahi; Saeid Safari
Journal:  Trauma Mon       Date:  2013-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.